Nonribosomal peptides (NRPs) are of great pharmacological importance, but there is currently no technology for highthroughput NRP 'dereplication' and sequencing. We used multistage mass spectrometry followed by spectral alignment algorithms for sequencing of cyclic NRPs. We also developed an algorithm for comparative NRP dereplication that establishes similarities between newly isolated and previously identified similar but nonidentical NRPs, substantially reducing dereplication efforts.
The classical protein synthesis pathway (translation of template mRNA) is not the only mechanism for cells to assemble amino acids into proteins or peptides. Nonribosomal peptide synthesis is performed by nonribosomal peptide (NRP) synthetases that represent both the mRNA-free template and building machinery for the peptide biosynthesis 1 . NRP synthetases produce NRPs that are not directly inscribed in genomes and thus cannot be inferred with traditional DNA sequencing. NRPs are of great pharmacological importance as they have been optimized by evolution for chemical defense and communication. Starting from penicillin, NRPs and other natural products have an unparalleled track record in pharmacology: most anticancer and antimicrobial agents are natural products or their derivatives 2 . NRPs include antibiotics, antiviral and antitumor agents, immunosuppressors and toxins.
Most NRPs contain nonstandard amino acids, increasing the number of possible building blocks from 20 (in standard ribosomal peptides) to several hundred (Supplementary Table 1 ). Previous methods for NRP characterization are based on nuclear magnetic resonance (NMR) spectroscopy and are time-consuming and errorprone [3] [4] [5] . Therefore, there is a need for the efficient structure elucidation of NRPs. Furthermore, substantial efforts in activity screening can be saved if newly isolated compounds can be rapidly associated to a known compound by 'dereplication' 6 . Dereplication refers to the process of screening for active compounds in a mixture discarding those that have been previously studied to avoid recharacterization.
In a pioneering study 7 , a cyclic algal peptide had been linearized and manually sequenced using tandem mass spectrometry (MS 2 ). This approach, although successful, did not result in a robust NRP sequencing technique as most NRPs evade linearization attempts. Characterization of hormothamnin A is another example of mass spectrometry-based NRP sequencing 8 . Furthermore, structural variants of antimicrobial agent tyrothricin had been characterized from a mixture of NRPs 9 , using tandem mass spectrometry. In a similar experiment 10 , new variations of streptocidins had also been sequenced. However, no automatic tool had been created from these studies.
We compared spectra of similar but nonidentical NRPs, enabling 'comparative dereplication' that establishes the similarity between a newly isolated and a previously identified similar (rather than identical) compounds. This is in contrast to the classical definition of dereplication, which only considers identical compounds. Because many NRPs are produced as related analogs (for example, 61 out of 90 cyanopeptides recently identified in drinking water are variants of known peptides 11 ), comparative dereplication can reduce NRP characterization efforts from weeks to minutes. For example, cyanopeptide X was an unknown bioactive compound (currently known as desmethoxymajusculamide C) when our project started in 2007 but was sequenced using NMR spectroscopy in 2008. The effort invested in analyzing this NRP in 2007 would have been saved if our algorithm, NRP-dereplication, were available. Indeed, NRP-dereplication revealed that cyanopeptide X is related to majusculamide C. Another example is compound 879 that had been assumed to be new but was found to be known during the patent application. NRP-dereplication revealed that compound 879 is neoviridogrisen. NRP-dereplication derives a sequence of an unknown compound given a database of known cyclic peptides (provided a related peptide is known). In the cases when no related NRPs are known, we performed de novo sequencing with NRP-sequencing, a self-alignment-based algorithm, and NRP-tagging, an approach that uses frequently occurring amino acid tags for peptide reconstruction. We also reconstructed cyanopeptide X, which is to our knowledge the first report of automated de novo reconstruction of a cyclic peptide by mass spectrometry.
When analyzing a cyclic peptide using mass spectrometry, the MS 2 stage amounted to breaking (linearizing) the cyclic peptide into linear peptides with the same parent mass (Fig. 1a-e) . The next stage of mass spectrometry (MS 3 ) breaks the different linearized versions of the cyclic peptide, resulting in the difficult problem of interpreting a MS 3 spectrum of different (but related) peptides. The theoretical MS 3 spectrum, spectrum(P) of the cyclic peptide P ¼ p 1 yp n is thus the superposition of the theoretical spectra spectrum(P i ) of n linear peptides P i ¼ p i yp n p 1 yp iÀ1 for i ¼ 1yn (Fig. 1a-e and Supplementary Fig. 1 ).
Comparative dereplication can be formulated as the cyclic peptide dereplication problem: given an experimental spectrum S, a cyclic peptide P and a parameter k (maximum number of mutations or modifications), find a cyclic peptide P ¢ with at most k mutations or modifications from P that maximizes the number of shared masses between S and the theoretical spectrum of P ¢.
We addressed the cyclic peptide dereplication problem for the most relevant case k r 1. Given the MS 3 spectrum of an unknown peptide P ¢, and the sequence of a known peptide P that differs from P ¢ by a single mutation at an unknown position x, NRP-dereplication derives P ¢. NRP-dereplication is based on the observation that most peaks shared between the experimental spectrum of P ¢ and theoretical spectrum P correspond to subpeptides that do not contain position x (0-correlated subpeptides). Conversely, most peaks in the experimental spectrum P ¢ that differ from the peaks in the theoretical spectrum of P by d ¼ mass(P ¢) À mass(P) correspond to subpeptides that contain position x (d-correlated subpeptides). The 'coverage' of a position x is defined as the number of 0-correlated subpeptides containing that position, plus the number of d-correlated subpeptides not containing that position. Thus, correlated subpeptides (both 0-correlated and d-correlated) have a potential to reveal the differing amino acid as the amino acid with the minimum coverage. For example, the drop in coverage at ornithine ( Supplementary Fig. 2 ) allows one to dereplicate the experimental spectrum of tyrocidine C1 using sequence of tyrocidine C.
As the peptide P to be used for dereplication is not known in advance, every NRP spectrum needs to be compared to a database of known cyclic peptides such as Norine 12 . NRP-dereplication can localize the single mutation using the top-scoring peptide in the Norine database (Supplementary Table 2 ).
The tyrocidine family presents an ideal test for NRP-dereplication because tyrocidine A, B and C are in the Norine database, whereas tyrocidines A1, B1 and C1 are not. NRP-dereplication showed that spectra from tyrocidine A, B and C had top hits corresponding to Norine-database peptides, whereas their A1, B1 and C1 counterparts were mapped to high-scoring matches with one mutation (Supplementary Table 2 ). The correct mutated position is also localized by NRP-dereplication as the position with minimum coverage for all compounds we analyzed that had a closely related compound in the NRP database. NRP-dereplication generated only two high-scoring false hits representing very short peptides (H8495 and BQ123), but closer examination revealed that the matches were correlated to the query peptides. We conducted additional experiments that demonstrated that NRP-dereplication can localize the correct position of the mutation when k ¼ 1 ( Supplementary Fig. 3 ).
In the case where no related peptide is known (and thus NRP-dereplication is not applicable), we formulated the cyclic peptide sequencing problem: given an experimental spectrum S, find a cyclic peptide P maximizing the number of shared masses between S and the theoretical spectrum of P. Reconstructing the cyclic peptide P from its theoretical spectrum, spectrum(P), amounts to the cyclic version of the partial digest problem 13 . 
BRIEF COMMUNICATIONS
However, it is not clear how to extend the algorithms for the partial digest problem 13, 14 to a cyclic setup. Furthermore, reconstructing P from its experimental MS 3 spectrum S is a difficult problem because the contributions of different linear versions of P to the experimental spectrum are nonuniform. However, spectral convolution and spectral alignment 15 can reveal similarities between related spectra. Because an MS 3 spectrum of a cyclic peptide is a superposition of spectra of related linearized peptides, spectral autoconvolution and autoalignment reveal key features of the cyclic peptide. Autoconvolution of a spectrum S with offset x is defined as the number of masses s in S such that s À x is also a mass in S. We defined the 'cyclic' autoconvolution, conv(S,x), as the number of masses s in S such that either (s À x) or (s À x) + precursorMass(S) is also a mass in S. For example, high-scoring positions of the autoconvolution of seglitide revealed masses of amino acids of the NRP (Fig. 1e) . Furthermore, the largest peak conv(S,85) ¼ 14 corresponded to the mass of the methylated alanine (Ala +14 ). The other five amino acids in seglitide are also represented by prominent peaks at positions 99, 128, 147, 163 and 186 with conv(S,x) Z 8, corresponding to their integer masses in daltons. Spectral autoconvolution (Fig. 1e) is a computational approach to derive residue masses of cyclic peptides.
Autoalignment of a spectrum S with offset x is defined as the set of peaks S x ¼ {s: s A S and (s À x) A S}. Autoalignment can be viewed as a virtual spectrum with parent mass precursorMass(S) À x ( Supplementary Fig. 4 ). For seglitide, S 85 (x ¼ 85 maximizes conv(S,x) for seglitide) corresponds to the alignment between A +14 YWKVF and YWKVFA +14 .
Using the concepts of autoconvolution and autoalignment, we created NRP-sequencing, an algorithm to solve the cyclic peptide sequencing problem that does not require prior knowledge of the amino acid masses in the compound. NRP-sequencing first uses the MS 3 autoconvolution to derive the set of possible amino acid masses and then uses the MS 3 autoalignment using the top k possible offset masses, x, to construct a consensus spectrum S x for each x. NRP-sequencing then generates all possible reconstructions for each S x and reranks all generated cyclic peptides according to their matches to the MS n spectra (for n ¼ 3, 4 and 5). Details on NRP-sequencing are given in Supplementary Note 1. In default mode, NRPsequencing selects the masses of the top 20 autoconvolution masses in the interval 57-200 Da and combines them with the masses of standard amino acids. NRPsequencing could generate the correct sequence (among the set of generated reconstructions) in all cases when the resulting set of masses contained all amino acid masses in the NRP (11 out of 18 compounds). Moreover, in almost all cases the correct sequences were ranked as the top-scoring reconstruction (Supplementary Table 3 ). However, the success of NRPsequencing is constrained by the ability to determine all amino acid masses by autoconvolution.
Because some positions are less prone to breakage than others, recovering all amino acid masses in an NRP using autoconvolution may be an unattainable goal. NRP-tagging attempts to reconstruct gapped peptides from MS 3 spectra of cyclic peptides (Fig. 1g) . Spectra of cyclic peptides are superpositions of related (cyclically shifted) linear peptides that tend to have the same tags repeated in the spectrum. Given an MS 3 spectrum, we found all 2-amino-acid tags XY (defined by triplets of peaks s, s + X, s + X + Y in the spectrum) and selected all frequent tags (for example, tags repeated 3 or more times). For example, if a tag XY starts at positions s, s + A and s + A + B, then masses A and B may represent two other (adjacent) amino acids in the cyclic peptide (Fig. 1g) . NRP-tagging first constructs a gapped peptide (for example, 85, 163, 186, 128 and 246 Da for seglitide, indicating integer masses of single or combined amino acids) and then attempts to extend it into fulllength de novo reconstructions (for example, 85, 163, 186, 128, 99 and 147 Da, indicating integer masses of amino acids in seglitide). As gapped peptides often contain masses representing combined masses of adjacent amino acids (for example, 246 ¼ 99 + 147 Da), NRP-tagging attempts to partition each mass in the gapped peptide into smaller masses (Supplementary Note 2). Similar to algorithms for sequencing linear peptides, NRP-tagging typically brings the correct peptide close to the top of the list of the high-scoring peptides ( Table 1) . This feature facilitates subsequent analysis of NRPs, for example, it allows one to correlate high-scoring reconstructions with NMR spectroscopy data. Moreover, the top-scoring peptide returned by NRP-tagging typically have minor differences as compared to the correct peptide, for example, combining masses of adjacent amino acids or choosing a mass with known offset. Using mass spectrometry for NRP interpretation is a 'Catch-22' situation. On the one hand, there are no algorithms for interpretation of NRP spectra, thus providing little incentive for generating NRP spectra. On the other hand, shortage of NRP spectra slows down development of algorithms for NRP interpretation because spectral datasets are needed to develop such algorithms. Here we attempted to break this unfortunate cycle that will hopefully motivate the natural-product researchers to begin generating NRP spectra.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemethods/.
Note: Supplementary information is available on the Nature Methods website.
